Douglas Arbetter
Impact in
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management
-
- Atrial Fibrillation Management and Outcomes
- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases
Papers in
-
- Asthma and respiratory diseases 5
-
- Venous Thromboembolism Diagnosis and Management 4
- Co-authors
- C. Michael Gibson (7 shared papers)Serge Korjian (6 shared papers)Yazan Daaboul (6 shared papers)Purva Jain (5 shared papers)Robert A. Harrington (4 shared papers)Gerald Chi (4 shared papers)Samuel Z. Goldhaber (6 shared papers)Alex Gold (5 shared papers)
- Journals
- Infectious Diseases and Therapy (3 papers)Circulation (2 papers)Journal of Allergy and Clinical Immunology (2 papers)Clinical Infectious Diseases (1 paper)European Respiratory Journal (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Douglas Arbetter
15 papers receiving 378 citations
Douglas Arbetter's Hit Papers
Peers
Comparison fields: 5 of 49
- Internal Medicine 123
- Cardiology and Cardiovascular Medicine 149
- Infectious Diseases 109
- Transplantation 5
- Hematology 21
Countries citing papers authored by Douglas Arbetter
This map shows the geographic impact of Douglas Arbetter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Arbetter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Arbetter more than expected).
Fields of papers citing papers by Douglas Arbetter
This network shows the impact of papers produced by Douglas Arbetter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Arbetter. The network helps show where Douglas Arbetter may publish in the future.
Co-authors
The 25 scholars most cited alongside Douglas Arbetter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2022 | 130 |
| 2 | 2016 | 64 | |
| 3 | 2016 | 50 | |
| 4 | 2016 | 40 | |
| 5 | 2017 | 34 | |
| 6 | 2024 | 34 | |
| 7 | 2024 | 7 | |
| 8 | 2017 | 7 | |
| 9 | 2023 | 6 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 2 | |
| 13 | 2024 | 1 | |
| 14 | 2016 | 1 | |
| 15 | 2017 | 1 | |
| 16 | 2022 | 0 | |
| 17 | 2025 | 0 | |
| 18 | 2021 | 0 |
About Douglas Arbetter
Douglas Arbetter is a scholar working on Physiology, Internal Medicine, Infectious Diseases, Cardiology and Cardiovascular Medicine and Surgery, having authored 18 papers that have together received 382 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (5 papers), Venous Thromboembolism Diagnosis and Management (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Atrial Fibrillation Management and Outcomes (3 papers), Health Systems, Economic Evaluations, Quality of Life (1 paper), Immunodeficiency and Autoimmune Disorders (1 paper), Eosinophilic Esophagitis (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Internal Medicine (123 citations), Cardiology and Cardiovascular Medicine (149 citations), Infectious Diseases (109 citations), Transplantation (5 citations) and Hematology (21 citations). Douglas Arbetter has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include C. Michael Gibson, Serge Korjian, Yazan Daaboul, Purva Jain, Robert A. Harrington, Gerald Chi, Samuel Z. Goldhaber, Alex Gold, Adrian F. Hernandez and Russel Hull. Their work appears in journals such as Infectious Diseases and Therapy, Circulation, Journal of Allergy and Clinical Immunology, Clinical Infectious Diseases and European Respiratory Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.